The use of highly active retroviral therapy to reduce HIV incidence at the population level

Anema, Aranka; Wood, Evan; Montaner, Julio S. G.
July 2008
CMAJ: Canadian Medical Association Journal;7/1/2008, Vol. 179 Issue 1, p13
Academic Journal
The author expresses his views on the highly active antiretroviral therapy as a possible drug in reducing human immunodeficiency syndrome (HIV) at population level. The author cites clinical trials showing that antiretroviral therapy has successfully prevents transmission of HIV from mother to child by lowering maternal plasma concentrations. The author also presented a table showing potential challenges and successes of the therapy to all people with HIV indication.


Related Articles

  • Antiretroviral Medication and HIV Prevention: New Steps Forward and New Questions. Mayer, Kenneth H.; Krakower, Douglas // Annals of Internal Medicine;2/21/2012, Vol. 156 Issue 4, p312 

    During the past 2 years, several pivotal clinical trials have proven that the use of antiretrovirals by HIV-infected and at-risk uninfected persons can decrease the probability of HIV being transmitted sexually. The initial chemoprophylaxis studies evaluated tenofovir administered topically or...

  • HIV Treatment as Prevention and "The Swiss Statement": in for a Dime, in for a Dollar? Cohen, Myron S. // Clinical Infectious Diseases;12/1/2010, Vol. 51 Issue 11, p1323 

    The author reflects on the prevention of vertical transmission of HIV in Switzerland. The author states that the transmission of HIV is reduced if an HIV patient receives antiretroviral therapy (ART) on a short term. The author notes that ART causes to decrease the viral load and transmission...

  • Prevention of mother-to-child transmission of HIV in Haiti. Deschamps, Marie-Marcelle; Noel, Francine; Bonhomme, Jerry; Dévieux, Jessy G.; Saint-Jean, Gilbert; Yuwei Zhu; Wright, Peter; Pape, Jean W.; Malow, Robert M. // Revista Panamericana de Salud Publica;Jan2009, Vol. 25 Issue 1, p24 

    Objectives. To describe the effectiveness of a program designed to reduce the rate of mother-to-child transmission (MTCT) of HIV at the primary HIV testing and treatment center in Haiti between 1999 and 2004. Methods. All pregnant, HIV-positive women who attended the major HIV testing and...

  • Defining HIV Susceptibility to New Antiretroviral Agents--Darunavir. Haubrich, Richard // Journal of Infectious Diseases;10/15/2007, Vol. 196 Issue 8, p1125 

    The article presents the author's comment on issues concerning decisions-making in selection of antiretroviral agents for treatment of human papillomavirus (HPV) disease in various clinical settings. The author appreciated the study by Yumi Mitsuya and colleagues on Darunavir resistance...

  • Participants as community-based peer educators: Impact on a clinical trial site in KwaZulu-Natal. Naidoo, Sarita; Morar, Neetha S.; Ramjee, Gita // South African Journal of Science;Jul/Aug2013, Vol. 109 Issue 7/8, p1 

    Participant recruitment, retention and product adherence are necessary to measure the efficacy or effectiveness of an intervention in a clinical trial. As part of a Phase III HIV prevention trial in a rural area in Kwazulu-Natal, South Africa, a peer educator programme was initiated to aid in...

  • HPTN 052 HIV Prevention Trial Named Top 2011 Breakthrough. Breindl, Anette // BioWorld Today;12/27/2011, Vol. 22 Issue 247, p1 

    The article announces that the HPTN 052 study was adjudged as the 2011 Breakthrough of the Year by "Science" magazine and the American Association for the Advancement of Science. The research is stated to be testing the theory that medicine can be used to prevent the spread of a disease....

  • Vaginal gel may help prevent HIV.  // Contemporary Sexuality;Sep2010, Vol. 44 Issue 9, p6 

    This article reports on a study of vaginal gels that contain the antiretroviral drug tenofovir and whether they can help prevent human immunodeficiency virus (HIV).

  • Early drug therapy reduces HIV transmission, study says. Taylor, Billy // Pink Paper;5/20/2011, p1 

    The article provides information on a medical study which evaluated the effectiveness of anti-retroviral therapy in preventing HIV transmission.

  • Daily pill for HIV-negative people can prevent HIV.  // Africa Health;Jul2011, Vol. 33 Issue 5, p10 

    The article reports on findings of the two studies which discover that a daily antiretroviral tablet can prevent heterosexual human immunodeficiency virus (HIV) transmission.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics